Australia markets closed

PharmAust Limited (PAA.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0700+0.0010 (+1.45%)
At close: 02:45PM AEDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
3,381
3,381
2,140
3,196
3,670
Cost of revenue
314.343
314.343
225.318
246.157
333.632
Gross profit
3,067
3,067
1,915
2,950
3,337
Operating expenses
Research development
758.655
758.655
554.144
605.351
1,039
Selling general and administrative
4,742
4,742
3,852
4,241
4,323
Total operating expenses
5,816
5,816
4,706
5,121
5,534
Operating income or loss
-2,749
-2,749
-2,791
-2,171
-2,197
Interest expense
88.511
88.511
78.986
118.495
47.822
Total other income/expenses net
1,129
1,129
1,517
924.229
676.299
Income before tax
-1,708
-1,708
-1,337
-1,362
-1,551
Income tax expense
0
0
0
0
0
Income from continuing operations
-1,708
-1,708
-1,337
-1,362
-1,551
Net income
-1,708
-1,708
-1,337
-1,362
-1,551
Net income available to common shareholders
-1,708
-1,708
-1,337
-1,362
-1,551
Basic EPS
-
-
-0.00
-0.00
-0.01
Diluted EPS
-
-
-0.00
-0.00
-0.01
Basic average shares
-
-
315,740
296,085
218,519
Diluted average shares
-
-
315,740
296,085
218,519
EBITDA
-
-1,305
-958.355
-968.858
-1,331